Cargando…

Case report: Clinical management of recurrent small cell lung cancer transformation complicated with lung cancer-induced acute pancreatitis after lung adenocarcinoma surgery

In the diagnosis and treatment of non-small cell lung cancer (NSCLC), the histological type may change from lung adenocarcinoma to lung squamous cell cancer or small cell lung cancer (SCLC). Pancreatic metastasis is extremely rare in advanced lung cancer, and pancreatitis characterized by lung cance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Suyun, Guo, Ningjing, Zhang, Qianyuan, Wang, Yao, Yang, Sheng, Chen, Xiangqi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644230/ https://www.ncbi.nlm.nih.gov/pubmed/38026982 http://dx.doi.org/10.3389/fphar.2023.1259221

Ejemplares similares

To explore the effect of kaempferol on non-small cell lung cancer based on network pharmacology and molecular docking
por: Zhang, Junli, et al.
Publicado: (2023)

XPC Protein Improves Lung Adenocarcinoma Prognosis by Inhibiting Lung Cancer Cell Stemness
por: Wang, Weiyu, et al.
Publicado: (2021)

Effect and mechanism of miR-146a on malignant biological behaviors of lung adenocarcinoma cell line
por: Yuan, Fang, et al.
Publicado: (2020)

Zengshengping improves lung cancer by regulating the intestinal barrier and intestinal microbiota
por: Sun, E., et al.
Publicado: (2023)

Current status of immunotherapy for non-small cell lung cancer
por: Yang, Tao, et al.
Publicado: (2022)

The clinicopathologic of pulmonary adenocarcinoma transformation to small cell lung cancer
por: Yang, Haiyan, et al.
Publicado: (2019)

Clinicopathological features of patients with transformation from EGFR mutant lung adenocarcinoma to small cell lung cancer
por: Bai, Wenwen, et al.
Publicado: (2021)

Targeting glycolysis in non-small cell lung cancer: Promises and challenges
por: Xu, Jia-Qi, et al.
Publicado: (2022)

RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer
por: Niederst, Matthew J., et al.
Publicado: (2015)

Recent progress in targeted therapy for non-small cell lung cancer
por: Xiao, Yanxia, et al.
Publicado: (2023)

Ureteral metastasis of small cell lung cancer transformed from lung adenocarcinoma: A case report
por: Wang, Yi, et al.
Publicado: (2022)

Histological transformation of lung adenocarcinoma to small cell lung cancer with mutant C797S conferring acquired resistance to osimertinib
por: Ren, Xiaohui, et al.
Publicado: (2020)

Anticancer Effects of Amlodipine Alone or in Combination With Gefitinib in Non-Small Cell Lung Cancer
por: Fu, Bingjie, et al.
Publicado: (2022)

Rechallenge of immunotherapy beyond progression in patients with extensive-stage small-cell lung cancer
por: Li, Lingling, et al.
Publicado: (2022)

Anti-Proliferative and Apoptosis-Inducing Effect of Theabrownin against Non-small Cell Lung Adenocarcinoma A549 Cells
por: Wu, Feifei, et al.
Publicado: (2016)

Berberine Suppresses Lung Metastasis of Cancer via Inhibiting Endothelial Transforming Growth Factor Beta Receptor 1
por: Tian, Wenjia, et al.
Publicado: (2022)

Significance of genetic sequencing in patients with lung adenocarcinoma with transformation to small cell lung cancer: a case report and systematic review
por: Zhang, Cuicui, et al.
Publicado: (2020)

Prediction of EGFR Mutation Status in Non–Small Cell Lung Cancer Based on Ensemble Learning
por: Feng, Youdan, et al.
Publicado: (2022)

Function and prognostic value of basement membrane -related genes in lung adenocarcinoma
por: Zhang, Yurong, et al.
Publicado: (2023)

Small cell lung cancer transformation after EGFR-TKIs treatment in lung adenocarcinoma: A case report and literatures review
por: Chen, Xiaoli, et al.
Publicado: (2023)

Bioinformatics-based screening of key genes for transformation of tyrosine kinase inhibitor-resistant lung adenocarcinoma to small cell lung cancer
por: Zhang, Ying, et al.
Publicado: (2023)

Therapeutic Effect of Repurposed Temsirolimus in Lung Adenocarcinoma Model
por: Chang, Hsuen-Wen, et al.
Publicado: (2018)

Comprehensive analysis of Cuproplasia and immune microenvironment in lung adenocarcinoma
por: Kuang, Junjie, et al.
Publicado: (2023)

Case Report: Etoposide-nedaplatin induced rhabdomyolysis in a small cell lung cancer patient
por: Xu, Xiaohu, et al.
Publicado: (2023)

FDX1 can Impact the Prognosis and Mediate the Metabolism of Lung Adenocarcinoma
por: Zhang, Zeyu, et al.
Publicado: (2021)

Systematic Transcriptome Analysis Reveals the Inhibitory Function of Cinnamaldehyde in Non-Small Cell Lung Cancer
por: Chen, Ru, et al.
Publicado: (2021)

The Role of Tumor Inflammatory Microenvironment in Lung Cancer
por: Tan, Zhaofeng, et al.
Publicado: (2021)

Discovery of Small Molecule NSC290956 as a Therapeutic Agent for KRas Mutant Non-Small-Cell Lung Cancer
por: Zhang, Jiaxin, et al.
Publicado: (2022)

Sheep tail fat inhibits the proliferation of non-small-cell lung cancer cells in vitro and in vivo
por: Xu, Changzhi, et al.
Publicado: (2022)

Whole exome sequencing (WES) analysis of transformed small cell lung cancer (SCLC) from lung adenocarcinoma (LUAD)
por: Xie, Tongji, et al.
Publicado: (2020)

Clinicopathologic and molecular characteristics of EGFR-mutant lung adenocarcinomas that transform to small cell lung cancer after TKI therapy
por: Yu, Li, et al.
Publicado: (2022)

Digoxin Enhances the Anticancer Effect on Non-Small Cell Lung Cancer While Reducing the Cardiotoxicity of Adriamycin
por: Wang, Yingying, et al.
Publicado: (2020)

Transformation to Small Cell Lung Cancer of Pulmonary Adenocarcinoma: Clinicopathologic Analysis of Six Cases
por: Ahn, Soomin, et al.
Publicado: (2016)

Lung adenocarcinoma-related target gene prediction and drug repositioning
por: Huang, Rui Xuan, et al.
Publicado: (2022)

Hesperidin Inhibits Lung Cancer In Vitro and In Vivo Through PinX1
por: Yao, Yang, et al.
Publicado: (2022)

Metallodrugs in the battle against non-small cell lung cancer: unlocking the potential for improved therapeutic outcomes
por: Xu, Xianzhi, et al.
Publicado: (2023)

Prognosis of Lung Adenocarcinoma Patients With NTRK3 Mutations to Immune Checkpoint Inhibitors
por: Niu, Yuchun, et al.
Publicado: (2020)

Identification of a New Potent Inhibitor Targeting KRAS in Non-small Cell Lung Cancer Cells
por: Xie, Chun, et al.
Publicado: (2017)

miRNAs in anti-cancer drug resistance of non-small cell lung cancer: Recent advances and future potential
por: Yan, Hang, et al.
Publicado: (2022)

Combined Small and Squamous Transformation in EGFR-mutated Lung Adenocarcinoma
por: Hakozaki, Taiki, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ip4j26q88bf4fnsqeibnqc2p59